Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klara Dorman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Cancer|May 9, 2026
The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in GermanyJulian W Holch, Jo-Ann Eisenburger, Antony Weber, et al.
Scientific Reports|December 8, 2025
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunich<sup>LMU</sup> outpatient clinicKlara Dorman, Kilian Breitenwieser, Laura Fischer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 4, 2023
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?Lena Weiss, Volker Heinemann, Laura E Fischer, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh<sup>®TM</sup>) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic CancerKlara Dorman, Stefan Boeck, Robert J Snijder, et al.
Targeted Oncology|June 30, 2025
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor BoardKlara Dorman, Christoph J Auernhammer, Christine Spitzweg, et al.
Targeted Oncology|February 28, 2023
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor BoardKlara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)David Witte, Ina Pretzell, Timm M Reissig, et al.
Targeted Oncology|August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center MunichDanmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Cancer|May 9, 2026
The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in GermanyJulian W Holch, Jo-Ann Eisenburger, Antony Weber, et al.
Scientific Reports|December 8, 2025
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunich<sup>LMU</sup> outpatient clinicKlara Dorman, Kilian Breitenwieser, Laura Fischer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 4, 2023
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?Lena Weiss, Volker Heinemann, Laura E Fischer, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh<sup>®TM</sup>) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic CancerKlara Dorman, Stefan Boeck, Robert J Snijder, et al.
Targeted Oncology|June 30, 2025
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor BoardKlara Dorman, Christoph J Auernhammer, Christine Spitzweg, et al.
Targeted Oncology|February 28, 2023
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor BoardKlara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)David Witte, Ina Pretzell, Timm M Reissig, et al.
Targeted Oncology|August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center MunichDanmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 2